CUE vs DD · rev $9.3M vs P/E 127, rev $12.39B
Cue Biopharma (CUE) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CUE currently screens at market cap $59.5M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CUE and DD stock pages for the full models.
Not investment advice.